Study of metabolic syndrome in patients with acanthosis nigricans.

Pandit BD Sharma PGIMS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月30日

试验速览

暂无简介。

•Patients with Acanthosis Nigricans aged >=18 years and comprising of both sexes.

•1) Patients with a history of intake of drugs which may lead to development of AN such
•as nicotinic acid, oral contraceptives, systemic steroids, diethylstilbestrol, antiretroviral
•drugs, and application of topical fusidic acid.
•2) Patients with pregnancy and in the postpartum period up to 6 months.
•3) Patients with family history of diabetes, hypertension and familial dyslipidemia,
•4) Patients with history of endocrine diseases like Cushing syndrome, acromegaly,
•pheochromocytoma, hyperthyroidism, glucagonoma.
•5) Participants with history of smoking and alcohol use.
•6) Patients with skin diseases that are known to be associated with metabolic syndrome
•such as psoriasis, lichen planus, androgenic alopecia, acne, systemic lupus
•erythematous, vitilgo etc.
•7) Patients with family history of acanthosis nigricans.
•8) Patients on drugs known to cause hypertension, hyperglycemia and hyperlipidemia.

发起方

Pandit BD Sharma PGIMS Rohtak